A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26230. Epub 2016 Sep 26.

Abstract

Transient myeloproliferative disorder (TMD) is a leukemia type that occurs typically in newborns. In Down syndrome, TMD is referred to as transient abnormal myelopoiesis (TAM).32 Recently, transientness has also been reported in acute myeloid leukemia patients with germline trisomy 21 mosaicism, and even in cases with somatic trisomy 21, with or without GATA1 mutations. TMD cases without trisomy 21 are rare, and recurrent genetic aberrations that aid in clinical decision-making are scarcely described. We describe here a TMD patient without trisomy 21 or GATA1 mutation in whom single-nucleotide polymorphism analysis of leukemic blasts revealed a novel combined submicroscopic deletion (5q31.1-5q31.3 and 8q23.2q24).

Keywords: Down syndrome; EXT1; GATA1; non-Down syndrome; transient abnormal myelopoiesis; transient leukemia; transient myeloproliferative disease; transient myeloproliferative disorder; trisomy 21.

Publication types

  • Case Reports

MeSH terms

  • Chromosomes, Human, Pair 5 / genetics*
  • Chromosomes, Human, Pair 8 / genetics*
  • Down Syndrome / genetics*
  • Down Syndrome / pathology
  • GATA1 Transcription Factor / genetics*
  • Humans
  • Infant, Newborn
  • Leukemia, Megakaryoblastic, Acute / genetics*
  • Leukemia, Megakaryoblastic, Acute / pathology
  • Polymorphism, Single Nucleotide / genetics*
  • Prognosis

Substances

  • GATA1 Transcription Factor
  • GATA1 protein, human